Navigation Links
GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology
Date:10/24/2008

GenOdyssee Has Received Notice of Allowance of European Patent Application

Covering Its Core Natural Evolution Technology Invented in 2002, and Received Broad Product Applications Protection Rights to All Cytokine

Families

PARIS, October 24 /PRNewswire/ -- GenOdyssee (GO), a biotechnology company dedicated to the discovery and development of improved 'next generation' human protein therapeutics, announced today that it has received notice of allowance from the European Patent Office of its Patent Application no.3 785 733.1 (PCT/EP03/13965) covering its core founding drug discovery technology process entitled "Method For Providing Natural Therapeutic Agents With High Therapeutic Index" for applications to all therapeutic cytokine families.

The company pioneered the vision that natural evolution has created in the general population superior genetic variants of key human protein therapeutic drugs as compared to the first wave of reference protein therapeutic variants isolated and developed during the first biotech boom in the 80s, which currently constitute standard of care.

"We have always believed that our technology has wide potential in the industry for discovery of second generation products. Our IFN and EPO products have been granted IP in all major countries in which we filed a product patent application, including the EU and the USA. Our IP portfolio now extends to 53 patents and patent applications in more than 19 countries. Importantly, the European patent office has now granted our technology broad product protection rights across all cytokine families. The granting of such broad IP product rights is relatively unusual and has been achieved in this case because GenOdyssee successfully demonstrated successful application of its technology across multiple products in various cytokine families," said Dr. David Brown, senior executive advisor for science & bus dev to GenOdyssee.

"This
'/>"/>

SOURCE GenOdyssee SA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
2. Alfacell Receives Going Concern Audit Opinion
3. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
4. NanoVibronix Receives FDA Clearance for its PainShield(TM) MD Device
5. PAREXEL Corporate Vice President Dr. Alberto Grignolo Receives Lifetime Achievement Award From Good Clinical Practice Journal
6. Medivation Receives Corporate Achievement Award From Huntingtons Disease Society of America
7. Bolder BioTechnology Receives $1.6 million NIH Grant to Continue Development of Multiple Sclerosis Drug
8. BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World
9. Althea Technologies Receives Fast Growth Honors: Deloitte Technology Fast 50 and San Diego Business Journal Fast 100 Awards for the Fifth Consecutive Year
10. POET Receives Additional $76 Million in Federal Funding For Commercialization of Cellulosic Ethanol
11. Imaging Diagnostic Systems Receives its First Order for its CT Laser Mammography System for Israel

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)...d to be able to find explosive materials and perso... searches, the National Institute of Standards and...nt of Homeland Security, has developed a new certi...al (SRM) 2905, Trace Particulate Explosives. Compa... SRM will be helpful in calibrating, testing and d...
(Date:11/18/2009)..., Nov. 18 Sangamo BioSci...data from the University of Pennsylvania investiga...nc finger nuclease (ZFN) based product, SB-728-T, ...sclosed on the internet. ,, Data were presented...ania School of Medicine from a single subject trea...
(Date:11/18/2009)...est Sussex, U.K. and CLEVELAND, Nov. 18 /PRNewswir...ces business and premier provider of diagnostic sy... labs, has expanded its East Grinstead, U.K., manu... meet increasing global demand for its Sensititre&...cation testing. The expanded facility has been ful...
(Date:11/18/2009)...omega Corporation and SwitchGear Genomics announce...eractions. , Madison, WI,...ion and SwitchGear Genomics announce a novel metho...ults of a study using the HaloCHIP™ System a... ability to correlate DNA binding events to transc...
Breaking Biology Technology:New NIST trace explosives standard slated for homeland security duty 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2
...BERKELEY, CA -- Make way for the real nanopod and ... researchers with the U.S. Department of Energys L...) and the University of California at Berkeley hav...single carbon nanotube, which makes it by several ..., A single carbon nanotube molecule serves simult...
... TALLAHASSEE, Fla. -- Engineers at Florida State U... have successfully tested a groundbreaking new mag...nanoscience and semiconductor research. , When th...perational in 2010, researchers will have the abil...not only down the bore, or center, of the magnet, ...
... DIEGO, Oct. 31 Senomyx, Inc. (Nasdaq:,SNMX), a l...logies to,discover and develop novel flavor ingred... announced today that its discovery and developmen... conclude on December 9,2007, which is one year ea...ement. The conclusion of this collaboration does n...
Other Biology Technology:Make way for the real nanopod 2Make way for the real nanopod 3Make way for the real nanopod 4Let there be light: new magnet design continues magnet lab's tradition of innovation 2Senomyx Announces Conclusion of Discovery and Development Collaboration With Kraft Foods Global, Inc. 2Senomyx Announces Conclusion of Discovery and Development Collaboration With Kraft Foods Global, Inc. 3
(Date:11/20/2009)...ax shives, and generated from Brassica carinata ,...gulf fields in spring, can be used to produce bioe...ried out by Spanish and Dutch researchers and publ...ergy Reviews . , "These studies evaluate, from an...oethanol from two, as yet unexploited sources of b...
(Date:11/19/2009)... end of the last ice age, North America,s vast ass...eatures as mammoths, mastodons, camels, horses, gr...tous slide to extinction. , And when their popul... large animals equaled or surpassed Africa,s wildl... novel ecosystem emerged as broadleaved trees once...
(Date:11/19/2009)...ulti-institutional effort co-led by three Cold Spr... today in publication of a landmark series of pape...nted detail the DNA sequence of maize ( Zea mays )...h American consumers, is one of the world,s most i... crop grown in the United States, representing $47...
Breaking Biology News(10 mins):Flax and yellow flowers can produce bioethanol 2After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4Exercise helps patients with non alcoholic fatty liver disease 50560 1Exercise helps patients with non alcoholic fatty liver disease 50560 2Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 1Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 2Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 3Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 4Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 5Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 1Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 2Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 3Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 4Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 5
...at showcase applications ranging from early-stage ... University of Houston will be well represented at...al Society (ACS), March 13 to 17 in San Diego. , F... and educational organization and the largest scie...membership of more than 159,000 chemists and chemi...
...ible to invasion by alien plant species, the const...ntributing to the accelerating spread of exotic aq... June 2005 issue of BioScience. John A. Havel of S... Lee and M. Jake Vander Zanden of the University o...ysical and biological properties of reservoirs mak...
...that infectious misformed proteins cause mad cow d...earchers at the University of Texas Medical Branch...roof yet that the mysterious and devastating brain...halopathies" (TSEs) are transmitted by an infectio... not a virus. TSEs, which can afflict both human b...
Other Biology News:Disease diagnosis, biodefense among UH chemical research projects 2Disease diagnosis, biodefense among UH chemical research projects 3Reservoirs may accelerate the spread of invasive aquatic species, researchers say 2Strongest proof yet found for prion hypothesis 2
Rabbit Anti-Human ALPHA-2-ANTIPLASMIN Polyclonal Antibody, Unconjugated from AbD Serotec
...ermostable recombinant DNA polymerase, which exhib...er molecular biology applications. Red Taq contain...cation of reactions to which enzyme was added and ...dye has no effect on downstream processes. Red Taq...
RNA oligos ready-to-use from Thermo Scientific
iEMS Incubator/Shaker HT from Thermo Scientific
Biology Products: